Orbital marginal cell lymphoma and mantle cell lymphoma subclone in patient with monoclonal gammopathy of unknown significance

Orbit. 2021 Jun;40(3):247-251. doi: 10.1080/01676830.2020.1760312. Epub 2020 May 3.

Abstract

Indolent lymphomas have the potential to transform into more aggressive phenotypes. This phenomenon is best exemplified by the transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma into diffuse large B-cell lymphoma. However, it is less common to find multiple small cell lymphomas in the orbit, particularly mantle cell lymphoma. We present a case of an extranodal marginal zone lymphoma arising in the orbit that acquired a subclonal t(11;14) (q13;32) CCND1-IGH translocation, giving rise to a subclone of mantle cell lymphoma. The management of this tumor was targeted towards the more aggressive mantle cell subclone. The tumor exhibited an incomplete response to rituximab alone. To the best of the authors' knowledge, this represents the first such case to be described irrespective of site of origin.

Keywords: Lymphoma transformation; mantle Cell Lymphoma; marginal Cell Lymphoma; orbital Lymphoma.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Humans
  • Leukemia, Lymphocytic, Chronic, B-Cell*
  • Lymphoma, B-Cell, Marginal Zone* / drug therapy
  • Lymphoma, Mantle-Cell* / drug therapy
  • Orbit
  • Paraproteinemias*